Clinical Trials Update Nov. 26, 2002
Multiple Sclerosis Insomnia Anxiety Disorders
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A clinical research study to assess the safety and effectiveness of a study drug that may alleviate the symptoms of pathological laughing and/or crying (pseudobulbar affect) in individuals with multiple sclerosis (MS). Research sites located throughout the United States.
A phase II, double-blind, placebo-controlled, randomized, parallel-group study of the efficacy and safety of investigational tablets in the treatment of insomnia. Research site located in New York, New York.
A research study on an investigational medication for the treatment of anxiety. Research site located in Woodstock, Vermont.
Copyright 2002 CenterWatch. All rights reserved.